Table 2 Comparison of clinical characteristics between lymphadenopathy KD and the without lymphadenopathy patients
Characteristics | Lymphadenopathy KD (N = 403) | Without lymphadenopathy KD (N = 243) | P value |
|---|---|---|---|
Age (months) | 36.0 (19.6–55.0) | 17.2 (8.6–32.4) | < 0.001 |
Male, n (%) | 253 (62.8%) | 146 (60.1%) | 0.494 |
Wight (Kg) | 13.6 (11.0–16.5) | 10.8 (8.8–13.0) | < 0.001 |
Transfer, n (%) | 206 (51.1%) | 109 (44.9%) | 0.123 |
Conjunctival injection, n (%) | 356 (88.3%) | 202 (83.1%) | 0.061 |
Hosdays (days) | 7.0 (5.4–8.4) | 7.0 (6.0–8.0) | 0.147 |
Incomplete KD, n (%) | 23 (5.9%) | 34 (14.2%) | < 0.001 |
Anomalies of the lips and oral mucosa, n (%) | 369 (91.6%) | 204 (84.0%) | 0.003 |
Exanthema, n (%) | 272 (67.5%) | 186 (76.5%) | 0.014 |
WBC (× 109/L) | 14.2 (11.1–17.8) | 14.2 (11.2–18.1) | 0.455 |
LYM (× 109/L) | 2.5 (1.4–3.8) | 3.5 (2.3–5.0) | < 0.001 |
ANC (× 109/L) | 10.8 (8.6–14.4) | 9.7 (7.0–13.2) | 0.015 |
HB (g/L) | 112.0 ± 11.8 | 111.0 ± 12.3 | 0.195 |
CRP (mg/L) | 78.4 (45.2–111.7) | 69.7 (39.6–108.3) | 0.318 |
PLT (× 109/L) | 337 (279–418) | 355 (294–433) | 0.016 |
ALB < 40 g/L | 154 (38.5%) | 78 (32.4%) | 0.123 |
ALT > 45U/L | 175 (43.9%) | 86 (35.5%) | 0.038 |
NT-proBNP (pg/ml) | 523 (230–1690) | 878 (300–2092) | 0.096 |
IVIG resistance, n (%) | 32 (7.9%) | 9 (3.7%) | 0.033 |
CAL, n (%) | 106 (26.3%) | 78 (32.2%) | 0.106 |
KDSS, n (%) | 11 (2.7%) | 0 (0.0%) | 0.009 |